CRISPR Therapeutics (CRSP) PT Raised to $45 at TD Cowen
Get Alerts CRSP Hot Sheet
Price: $56.82 -0.28%
Rating Summary:
19 Buy, 14 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Rating Summary:
19 Buy, 14 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Join SI Premium – FREE
TD Cowen analyst Tyler Van Buren raised the price target on CRISPR Therapeutics (NASDAQ: CRSP) to $45.00 (from $40.00) while maintaining a rating.
You May Also Be Interested In
- Designer Brands (DBI) PT Lowered to $6 at UBS
- Ser Educacional SA (SEER3:BZ) PT Raised to R$23 at JPMorgan
- GDS Holdings (GDS) PT Lowered to $51 at Raymond James
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share